Company Profile
CJ Bioscience provides microbiome solutions to address unmet medical needs in South Korea and globally. The company's platform is Ez-Mx, a bioinformatics-based platform for microbiome data analysis.
Its product pipeline includes CJRB-101 that is phase I clinical trial for solid tumors. Its portfolio also includes CJRB-201, CJRB-202, and CJRB-203 for inflammatory bowel diseases, CJRB-302 for Parkinson's diseases, and CJRB-401 and CJRB-402 for asthma Next-generation sequencing analysis services.
Its portfolio also includes EzBioCloud, a database and bioinformatics analysis portal for microbial research, EzBioCloud Pro, a next-generation analysis platform for infection diagnosis and microbial bioinformatics analysis, Gut Inside, a microbiome testing service, and TrueBac ID, a cloud-based service platform that can identify various bacterial species based on genomic data. Founded in 2009 and based in Seoul, South Korea, CJ Bioscience was formerly known as ChunLab, Inc. before rebranding in December 2021.